Familial Reducing Body Myopathy with Cytoplasmic Bodies and Rigid Spine Revisited: Identification of a Second LIM Domain Mutation in FHL1

Abstract

Objective: Reducing body myopathy (RBM) is a rare progressive disorder of muscle characterized by intracytoplasmic inclusions, which stain strongly with menadione-NBT (nitroblue tetrazolium). We recently identified the four and a half LIM domain gene FHL1 located on chromosome Xq26 as the causative gene for RBM. So far eight familial cases and 21 sporadic patients with RBM have been reported in the literature.

Methods: We ascertained a total of 8 members of a German family initially reported by Goebel et al. as a mixed myopathy with rigid spine myopathy and reducing as well as cytoplasmic bodies. Clinical findings in the original and additional family members have been reviewed. Mutation detection was performed by direct sequencing of FHL1 exons.

Results: We identified a novel mutation (p.C150R) in the second LIM domain of FHL1 in six family members (1 male, 5 females). The male index patient was the most affected member presenting with rigid spine, followed by rapidly progressive muscle weakness. He died from the consequences of respiratory insufficiency at the age of 29.5 years. His sister, mother, grandmother, aunt and female cousin all carried the mutation in the heterozygous state. The sister is clinically unaffected; their mother had myopathic changes in her muscle biopsy, while the grandmother showed first signs of weakness at 50 years of age. The 54-year-old aunt and her daughter are clinically asymptomatic.

Conclusion: We report a novel LIM2 domain mutation in FHL1 in a previously reported family with RBM with cytoplasmic bodies and spinal rigidity. While the male index patient was significantly affected, female carriers show varying manifestations and may be asymptomatic, likely reflecting varying degrees of X-inactivation. RBM continues to be associated with mutations in the LIM2 domain of FHL1. We also confirm our earlier observation that mutations at the N-terminal end of the LIM2 domain seem to be milder compared to mutations seen at the C-terminal part of the domain which cause severe disease even in female carriers.

Key words

FHL1 - reducing body myopathy - aggresomes - X-linked myopathy - LIM

References

• 1 Brooke MH, Neville HE. Reducing body myopathy.  Neurology. 1972;  22 829-840
• 2 Brown S, McGrath MJ, Ooms LM. et al . Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication.  J Biol Chem. 1999;  274 27083-27091
• 3 Goebel HH, Halbig LE, Goldfarb L. et al . Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy.  Neuropediatrics. 2001;  32 196-205
• 4 Gueneau L, Bertrand AT, Jais JP. et al . Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.  Am J Hum Genet. 2009;  85 338-353
• 5 Hubner G, Pongratz D. [Reducing body myopathy − ultrastructure and classification (author's transl)].  Virchows Archiv. 1981;  392 97-104
• 6 Kiyomoto BH, Murakami N, Kobayashi Y. et al . Fatal reducing body myopathy. Ultrastructural and immunohistochemical observations.  J Neurolog Sci. 1995;  128 58-65
• 7 McGrath MJ, Cottle DL, Nguyen MA. et al . Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly.  J Biol Chem. 2006;  281 7666-7683
• 8 Ng EK, Lee SM, Li HY. et al . Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1).  J Cell Biochem. 2001;  82 1-10
• 9 Ohsawa M, Liewluck T, Ogata K. et al . Familial reducing body myopathy.  Brain Dev. 2007;  29 112-116
• 10 Quinzii CM, Vu TH, Min KC. et al . X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.  Am J Hum Genet. 2008;  82 208-213
• 11 Reichmann H, Goebel HH, Schneider C. et al . Familial mixed congenital myopathy with rigid spine phenotype.  Muscle Nerve. 1997;  20 411-417
• 12 Schessl J, Zou Y, McGrath MJ. et al . Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.  J Clin Invest. 2008;  118 904-912
• 13 Schessl J, Taratuto AL, Sewry C. et al . Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.  Brain. 2009;  132 452-464
• 14 Schoser B, Goebel HH, Janisch I. et al . Consequences of mutations within the C terminus of the FHL1 gene.  Neurology. 2009;  73 543-551
• 15 Shalaby S, Hayashi YK, Goto K. et al . Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).  Neuromuscul Disord. 2008;  18 959-961
• 16 Shalaby S, Hayashi YK, Nonaka I. et al . Novel FHL1 mutations in fatal and benign reducing body myopathy.  Neurology. 2009;  72 375-376
• 17 Taniguchi Y, Furukawa T, Tun T. et al . LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein.  Mol Cell Biol. 1998;  18 644-654
• 18 Windpassinger C, Schoser B, Straub V. et al . An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.  Am J Hum Genet. 2008;  82 88-99

Correspondence